In the last trading session, 1.35 million Vera Therapeutics Inc (NASDAQ:VERA) shares changed hands as the company’s beta touched 1.16. With the company’s per share price at $23.56 changed hands at $0.91 or 4.02% during last session, the market valuation stood at $1.50B. VERA’s last price was a discount, traded about -119.06% off its 52-week high of $51.61. The share price had its 52-week low at $18.53, which suggests the last value was 21.35% up since then. When we look at Vera Therapeutics Inc’s average trading volume, we note the 10-day average is 1.7 million shares, with the 3-month average coming to 1.80 million.
Analysts gave the Vera Therapeutics Inc (VERA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.14. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 1 recommended VERA as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Vera Therapeutics Inc (NASDAQ:VERA) trade information
Instantly VERA was in green as seen at the end of in last trading. With action 8.82%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -30.13%, with the 5-day performance at 8.82% in the green. However, in the 30-day time frame, Vera Therapeutics Inc (NASDAQ:VERA) is 18.21% up. Looking at the short shares, we see there were 9.56 million shares sold at short interest cover period of 3.76 days.
The consensus price target for the stock as assigned by Wall Street analysts is 65, meaning bulls need an upside of 63.75% from its current market value. According to analyst projections, VERA’s forecast low is 65 with 65 as the target high. To hit the forecast high, the stock’s price needs a -175.89% plunge from its current level, while the stock would need to soar -175.89% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 4.49%. The 2025 estimates are for Vera Therapeutics Inc earnings to decrease by -19.07%, but the outlook for the next 5-year period is at 10.74% per year.
VERA Dividends
Vera Therapeutics Inc is expected to release its next quarterly earnings report on 2025-May-06.
Vera Therapeutics Inc (NASDAQ:VERA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 5.16% of Vera Therapeutics Inc shares while 112.41% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 118.52%. There are 112.41% institutions holding the Vera Therapeutics Inc stock share, with AVORO CAPITAL ADVISORS LLC the top institutional holder. As of 2024-06-30, the company held 7.8745% of the shares, roughly 4.31 million VERA shares worth $155.92 million.
PRICE T ROWE ASSOCIATES INC /MD/ holds the second largest percentage of outstanding shares, with 6.6147% or 3.62 million shares worth $130.98 million as of 2024-06-30.
